RNA Disruption Assay (RDA)-Breast Cancer Response Evaluation for Individualized Therapy
Clinical trial NCT03524430 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03524430
- Sponsor
- Rna Diagnostics Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-26
- Primary completion
- 2026-10-30
- Enrollment
- 801
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.